Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Mycoses 3Leukemia, Myeloid, Acute 3Myelodysplastic Syndromes 2Leukemia 2Hematologic Neoplasms 2Neutropenia 1Neoplasms 1Invasive Fungal Infections 1Bronchiolitis Obliterans Syndrome 1Bone Marrow Neoplasms 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

Voriconazole 4Caspofungin 4posaconazole 3Fluconazole 3Itraconazole 2Amphotericin B 2liposomal amphotericin B 1Standard of Care 1ProMune 1Lymphatic Irradiation 1Levofloxacin 1Cyclosporine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Mycoses × posaconazole × Clear all
NCT02358499 2020-12-22

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

Children's Mercy Hospital Kansas City

Phase 1 Completed
31 enrolled
Other hematologic neoplasm

Bone Marrow Failure Disorders, Leukemia, Mycoses

NCT00936117 2019-02-27

Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia

M.D. Anderson Cancer Center

Phase 2 Completed
25 enrolled 5 charts
Other hematologic neoplasm

Leukemia, Mycoses, Bone Marrow Neoplasms

NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Merck Sharp & Dohme LLC

Phase 4 Completed
75 enrolled 14 charts
Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡